Tiratricol
Suppliers
Names
[ CAS No. ]:
51-24-1
[ Name ]:
Tiratricol
[Synonym ]:
triiodothyroacetic acid
Tiratricol,3,3',5-triiodothyroacetic acid
3,5,3'-triiodothyroacetic acid
Benzeneacetic acid, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-
3,3',5-TRIIODOTHYROACETIC ACID
3,3',5-Triiodo-4-(4-hydroxyphenoxy)phenylacetic Acid
Triac
3,5-Diiodo-4-(3-iodo-4-hydroxyphenoxy)phenylacetic Acid
[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid
Tiratricol
Chemical & Physical Properties
[ Density]:
2.5±0.1 g/cm3
[ Boiling Point ]:
531.6±50.0 °C at 760 mmHg
[ Melting Point ]:
181.5ºC
[ Molecular Formula ]:
C14H9I3O4
[ Molecular Weight ]:
621.932
[ Flash Point ]:
275.3±30.1 °C
[ Exact Mass ]:
621.763489
[ PSA ]:
66.76000
[ LogP ]:
5.47
[ Vapour Pressure ]:
0.0±1.5 mmHg at 25°C
[ Index of Refraction ]:
1.767
[ Storage condition ]:
-20°C
MSDS
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302-H312-H332
[ Precautionary Statements ]:
P280
[ Hazard Codes ]:
Xn: Harmful;
[ Risk Phrases ]:
R20/21/22
[ Safety Phrases ]:
36
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2918990090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2918990090
[ Summary ]:
2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
Chem. Res. Toxicol. 23 , 171-83, (2010)
Drug-induced liver injury is one of the main causes of drug attrition. The ability to predict the liver effects of drug candidates from their chemical structures is critical to help guide experimental...
Proc. Natl. Acad. Sci. U. S. A. 104 , 16074-9, (2007)
Current approaches to inhibit nuclear receptor (NR) activity target the hormone binding pocket but face limitations. We have proposed that inhibitors, which bind to nuclear receptor surfaces that medi...
J. Med. Chem. 54 , 8563-73, (2011)
The androgen receptor (AR) is the best studied drug target for the treatment of prostate cancer. While there are a number of drugs that target the AR, they all work through the same mechanism of actio...